多方向かつ段階的に進行する細胞分化における運命決定メカニズムの解明究領域略称:細胞運命制御

主な業績

2012年度 - 総説論文

* correspondence

*Koyasu S, Moro K.
Natural helper cells in the lung: good or bad help?
Immunity. 36: 317-319. 2012

Kurebayashi Y, Nagai S, Ikejiri A, Ohtani M, Ichiyama K, Baba Y, Yamada T, Egami S, Hoshii T, Hirao A, Matsuda S, Koyasu S*.
PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi-1 expression and nuclear translocation of ROR<gamma>
Cell Reports. 1(4):360-373. 2012.

Hoshii T, Tadokoro Y, Naka K, Ooshio T, Muraguchi T, Sugiyama N, Soga T, Araki K, Yamamura K, Hirao A*.
mTORC1 is essential for leukemia-propagation but not stem cell self-renewal.
J Clin Invest. 122(6):2114-29. 2012.

Kamiya A. and *Miyajima A.
Mice with artificial human liver (Commentary).
Hepatology. 55(3):974-7.2012.

*Taniuchi I, Osato M and Ito Y.
Runx1: No longer just for leukemia.
EMBO J. 31(21): 4098-4099.2012.

Ohtani M, Hoshii T, Fujii H, Koyasu S, Hirao A, Matsuda S*.
mTORC1 in Intestinal CD11c+CD11b+ Dendritic Cells Regulates Intestinal Homeostasis by Promoting IL-10 Production.
J Immunol. 188(10):4736-40. 2012.

Mochizuki-Kashio M, Went G, *Iwama A.
Tumor suppressor function of the polycomb group genes.
Cell Cycle. 11:2043-2044, 2012.

Shugo H†, Ooshio T†, Naito M, Naka K, Hoshii T, Tadokoro Y, Muraguchi T, Tamase A, Uema N, Yamashita T, Nakamoto Y, Suda T, Kaneko S, Hirao A*.
Nucleostemin in injury-induced liver regeneration.
Stem Cells Dev, 21(16):3044-54. 2012. 2012. †equally contribution

Midorikawa Y, Tsuji S, Takayama T, *Aburatani H.
Genomic approach towards personalized anticancer drug therapy.
Pharmacogenomics. 13(2): 191-9. 2012

Shimizu R, *Yamamoto M.
The contribution of GATA1 dysfunction to multi-step leukemogenesis.
Cancer Sci. 103(12):2039-44.2012.


Nishino T, Osawa M, *Iwama A.
New approaches to expand hematopoietic stem and progenitor cells.
Expert Opin Biol Ther. 12:743-756, 2012.

Kitamura T, Inoue D.
HDAC inhibitor-induced thrombocytepenia is caused by its unexpected target.
Exp Hematol. 40: 695-697. 2012.

*Nishina H.
[commentary] hDlk-1: A cell surface marker common to normal hepatic stem/progenitor cells and carcinomas.
J Biochem. 152, 121-123, 2012.

Hata S, *Nishina H.
[Letters to the Editor] Reply to Sun et al.: Targeting YAP acetylation in cancer.
J Biol Chem. 287(42):35443.2012

Sugiyama T, *Nagasawa T.
Bone marrow niches for hematopoietic stem cells and immune cells
Inflamm Allergy Drug Targets. 11: 201-206. 2012

*Koyasu S, Moro K.
Role of innate lymphocytes in infection and inflammation.
Front Immunol. 3: 1-13. 2012

Yamasaki T, Kawasaki H, *Nishina H.
[review] Diverse roles of JNK and MKK pathways in the brain.
J Signal Trans. 2012: 459265, 2012.

Sashida G and *Iwama A.
Epigenetic regulation of hematopoiesis.
Int J Hematol. 96(4):405-12.2012.

*Takubo K, Suda T.
Roles of the hypoxia response system in hematopoietic and leukemic stem cells.
Int J Hematol. 95: 478-483.2012.

*Minagawa K, Yamamori M, Katayama Y, Matsui T.
Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis.
Int J Hematol. 96: 10-25. 2012.

*Fujiwara T.
Genome-wide analysis of GATA transcription factor in hematopoietic cells.
Rinsho Ketsueki. 53: 287-294. 2012.



このページのTOPへ